These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3097356)

  • 21. 5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors.
    Abad A; Rosell R; Barnadas A; Carles J; Ribelles N; Solano V
    Ann Oncol; 1991 Feb; 2(2):153. PubMed ID: 2054318
    [No Abstract]   [Full Text] [Related]  

  • 22. Subcutaneously inoculated cells and implanted pancreatic cancer tissue show different patterns of metastases in Syrian golden hamsters.
    Morioka CY; Saito S; Ohzawa K; Asano S; Hibino Y; Nakada Y; Kita KI; Watanabe A
    JOP; 2000 Nov; 1(4):183-90. PubMed ID: 11856860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of combined use of CR1505 with UFT for the tumor growth of the subcutaneously transplanted pancreatic cancer in the Syrian golden hamsters].
    Tomioka M; Miyazaki N; Yamamoto M; Saito Y
    Nihon Shokakibyo Gakkai Zasshi; 1993 Mar; 90(3):693-9. PubMed ID: 8515583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Return trip" metastases from the liver to the pancreas in Syrian golden hamsters.
    Morioka CY; Saito S; Watanabe A
    In Vivo; 2000; 14(3):467-9. PubMed ID: 10904884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer.
    Smith FP; Rustgi VK; Schertz G; Woolley PV; Schein PS
    Cancer Treat Rep; 1982 Dec; 66(12):2095-6. PubMed ID: 6215982
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma.
    Bukowski RM; Schacter LP; Groppe CW; Hewlett JS; Weick JK; Livingston RB
    Cancer; 1982 Jul; 50(2):197-200. PubMed ID: 6211223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination therapy with lentinan, mitomycin c, 5-fluorouracil and radiation--a case of long-term survival of pancreas cancer after palliative surgery].
    Kunitomo K; Kawahito M; Miura M; Komi N
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1342-4. PubMed ID: 2437863
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of adenocarcinoma of the liver with mitomycin, hyaluronidase, and ethanol: an experimental study in the rat.
    Harnek J; Cwikiel W; Zoucas E; Seiving B; Stenram U
    Cardiovasc Intervent Radiol; 1998; 21(1):57-62. PubMed ID: 9473548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematoporphyrin derivative uptake and photodynamic therapy in pancreatic carcinoma.
    Schroder T; Chen IW; Sperling M; Bell RH; Brackett K; Joffe SN
    J Surg Oncol; 1988 May; 38(1):4-9. PubMed ID: 2967404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intratumoral injection therapy of mitomycin C adsorbed to activated carbon particles under ultrasound guidance for pancreatic cancer].
    Moriai T
    Nihon Shokakibyo Gakkai Zasshi; 1985 Dec; 82(12):2994. PubMed ID: 3938492
    [No Abstract]   [Full Text] [Related]  

  • 31. Different pattern of metastasis in liver implanted pancreatic cancer between young and old Syrian golden hamsters.
    Morioka CY; Saito S; Machado MC; Jukemura J; Bacchella T; Watanabe A
    In Vivo; 2005; 19(3):639-41. PubMed ID: 15875787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).
    Bitran JD; Desser RK; Kozloff MF; Billings AA; Shapiro CM
    Cancer Treat Rep; 1979; 63(11-12):2049-51. PubMed ID: 393388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homologous orthotopic implantation models of pancreatic ductal cancer in Syrian golden hamsters: which is better for metastasis research--cell implantation or tissue implantation?
    Morioka CY; Saito S; Ohzawa K; Watanabe A
    Pancreas; 2000 Mar; 20(2):152-7. PubMed ID: 10707930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
    Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
    Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of metastatic behavior of parental and metastatic pancreatic cancer cell lines in Syrian golden hamsters.
    Morioka CY; Saito S; Machado MC; Ohzawa K; Yamago GI; Bacchella T; Watanabe A
    In Vivo; 2004; 18(1):63-6. PubMed ID: 15011753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasoactive intestinal peptide inhibits the growth of hamster pancreatic cancer but not human pancreatic cancer in vivo.
    Poston GJ; Yao CZ; Upp JR; Alexander RW; Townsend CM; Thompson JC
    Pancreas; 1988; 3(4):439-43. PubMed ID: 3174607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas.
    Sternberg CN; Magill GB; Sordillo PP; Cheng EW
    Am J Clin Oncol; 1984 Oct; 7(5):529-33. PubMed ID: 6391145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term in vitro culture of hamster pancreatic β-cells and induction of adenocarcinoma by treatment with N-nitrosobis(2-oxopropyl)amine.
    Müller SA; Bläuer K; Ergin G; Bergmann F; Z'graggen K; Schmied BM; Ulrich A
    Pancreatology; 2012; 12(4):380-7. PubMed ID: 22898641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intratumoral treatment of pancreatic cancer with mitomycin-C adsorbed to activated carbon particles. A clinical trial on 15 cases.
    Moriai T; Makino TT; Ishii K
    Anticancer Res; 1989; 9(6):1799-804. PubMed ID: 2516716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.